Author

Ζήνων Ζήνωνος

Observed names: Z. Zenonos, Zenon A Zenonos, Zenon A. Zenonos, Zenon Zenonos

Institution: AstraZeneca (United Kingdom)

Observed institutions: AstraZeneca (United Kingdom), Wellcome Sanger Institute

ORCID: 0000-0003-3301-1809

Observed ORCID: 0000-0003-3301-1809

OpenAlex ID: A5007970285

Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1

2011 · Wei Wang, Jian Yang, et al. · Proceedings of the National Academy of Sciences · 252

Epistasis studies reveal redundancy among calcium-dependent protein kinases in motility and invasion of malaria parasites

2018 · Hanwei Fang, Ana Rita Gomes, et al. · Nature Communications · 70

Basigin is a druggable target for host-oriented antimalarial interventions

2015 · Zenon A. Zenonos, Sara K. Dummler, et al. · The Journal of Experimental Medicine · 70

A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates

2019 · Alexander D. Douglas, G. Christian Baldeviano, et al. · Nature Communications · 66

Adaptation of Plasmodium falciparum to humans involved the loss of an ape-specific erythrocyte invasion ligand

2019 · William R. Proto, Sasha V. Siegel, et al. · Nature Communications · 33

Barcoding Genetically Distinct Plasmodium falciparum Strains for Comparative Assessment of Fitness and Antimalarial Drug Resistance

2022 · Manuela Carrasquilla, Ndey Fatou Drammeh, et al. · mBio · 29

Towards a comprehensive Plasmodium falciparum merozoite cell surface and secreted recombinant protein library

2014 · Zenon A Zenonos, Julian C Rayner, et al. · Malaria Journal · 29

Immunomodulation of T- and NK-cell Responses by a Bispecific Antibody Targeting CD28 Homolog and PD-L1

2021 · Madhu Ramaswamy, Taeil Kim, et al. · Cancer Immunology Research · 21

Malaria Vaccine Development: Focusing Field Erythrocyte Invasion Studies on Phenotypic Diversity

2015 · Ambroise D. Ahouidi, Alfred Amambua-Ngwa, et al. · Trends in Parasitology · 14

APEX2-based proximity proteomic analysis identifies candidate interactors for Plasmodium falciparum knob-associated histidine-rich protein in infected erythrocytes

2024 · Sébastien Charneau, Lucas Silva de Oliveira, et al. · Scientific Reports · 11

Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers

2025 · Jason J. Zoeller, Ravinder Tammali, et al. · Clinical Cancer Research · 6

Clonal tree frequency analysis reveals affinity determinants and enables antibody lead optimization

2026 · Mark Waterhouse, Shuang Gu, et al. · mAbs

Supplementary Figure S7 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers

2025 · Jason J. Zoeller, Ravinder Tammali, et al.

Supplementary Table S6 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers

2025 · Jason J. Zoeller, Ravinder Tammali, et al.

Supplementary Methods S1 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers

2025 · Jason J. Zoeller, Ravinder Tammali, et al.

Supplementary Table S2 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers

2025 · Jason J. Zoeller, Ravinder Tammali, et al.

Supplementary Table S5 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers

2025 · Jason J. Zoeller, Ravinder Tammali, et al.

Supplementary Figure S2 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers

2025 · Jason J. Zoeller, Ravinder Tammali, et al.

Supplementary Table S1 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers

2025 · Jason J. Zoeller, Ravinder Tammali, et al.

Supplementary Table S4 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers

2025 · Jason J. Zoeller, Ravinder Tammali, et al.

Supplementary Figure S5 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers

2025 · Jason J. Zoeller, Ravinder Tammali, et al.

Supplementary Table S3 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers

2025 · Jason J. Zoeller, Ravinder Tammali, et al.

Supplementary Figure S1 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers

2025 · Jason J. Zoeller, Ravinder Tammali, et al.

Supplementary Table S7 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers

2025 · Jason J. Zoeller, Ravinder Tammali, et al.

Supplementary Figure S3 from Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers

2025 · Jason J. Zoeller, Ravinder Tammali, et al.

Works count: 35

Citation count: 601

H-index: 10

I10-index: 10